Human Health and Microbiome We need a stable, balanced gut microbiome (GM) to be healthy. Bacteriophages play an important role in maintaining healthy GM function. <Healthy Human Gut Phageome> by Manrique et al., published in PNSAS, investigated the relationship between human health and gut phageome,...
Arixa Pharmaceuticals™, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram-negative infections today announced that Pfizer’s Hospital Business has agreed to acquire Arixa. Arixa’s lead compound, ARX-1796, is an oral prodrug of avibactam, a beta lactamase inhibitor (BLI) that was FDA-approved in 2015 as part...
iNtRON Biotechnology has developed a LiliF™ GBN COVID-19 IgG Rapid Kit. LiliF™ GBN COVID-19 IgG Rapid Kit is a lateral flow chromatographic immunoassay for the detection of anti-SARS-CoV-2 IgG antibodies in human whole blood, serum or plasma. It is intended to be used by professionals...
In most recent news, Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company, announced that the Department of Defense (DoD) has awarded them $9.8 million for the research development of multiple Phase-1 high-priority, bacteriophage-based vaccine candidates against SARS-CoV-2. APT research contract with the DoD will only advance...
iNtODEWORLD’s Chief Operating Officer, H. Tim Min, and Project Coordinator, Minerva Marcano, will be attending the 2nd inaugural Phage Futures Congress 2020 being held in Washington D.C. from February 5-6, 2020. The conference is first of its kind to discuss how to translate phage-based application...
iNtRON Biotechnology attended the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2020. J.P. Morgan’s Healthcare Conference is Wall Street’s premier investor conference aimed exclusively towards companies defining the healthcare industry. J.P. Morgan Healthcare Conference continues their tradition of...